Park J H, Chen K W, Mueller T. "Method for the Synthesis of Dasatinib Impurity 29" [P]. US Patent, US 10015227 B2, 2021-08-22.
发明人徐明华,韩伟,刘建华. "A Process for Preparing High-Purity Dasatinib Impurity 29" [P]. 中国发明专利, 专利号 CN 111075899 A, 授权公告日 2019-07-06.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质29 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2021, 364, (10), 3153-3174.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质29 as an Impurity". Anal. Chem., 2017, 2088, (5), 4223-4241.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 29 Using HRMS and NMR". Chemosphere, 2016, 481, 9236-9245.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 达沙替尼杂质29 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2024, 611, (8), 6636-6658.